Medline, Inc. (MDLN)
43.82
+1.11
(+2.60%)
USD |
NASDAQ |
Jan 16, 15:54
Medline EPS Diluted (Quarterly): 0.4026 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Abbott Laboratories | 0.9146 |
| AIM ImmunoTech, Inc. | -1.567 |
| Perspective Therapeutics, Inc. | -0.3495 |
| Protalix Biotherapeutics, Inc. | 0.0291 |
| Armata Pharmaceuticals, Inc. | -0.7363 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 322.00M |
| Revenue (Quarterly) | 7.115B |
| Total Expenses (Quarterly) | 6.793B |
| Enterprise Value | 49.68B |
| Gross Profit Margin (Quarterly) | 23.87% |
| Profit Margin (Quarterly) | 4.53% |
| Earnings Yield | 3.61% |
| Operating Earnings Yield | 6.75% |
| Normalized Earnings Yield | 3.571 |